Shanghai Minwei Biotechnology Co., Ltd

This phase 2 trial tests an experimental drug called MWN105, given as a weekly injection, in adults who are overweight or have obesity but do not have diabetes. About 120 participants will receive different doses of MWN105 or a placebo for 24 weeks. The main goal is to see how mu…

This early-stage trial tests an investigational drug called MWN105, given as an injection under the skin, in healthy Chinese volunteers aged 18 to 45. The study aims to check the drug's safety, how the body processes it, and whether it triggers an immune response. Researchers wil…

This trial tests an oral medication called MWN109 in Chinese adults with type 2 diabetes, overweight, or obesity. Researchers want to see if the amount of water taken with the pill and the timing of the next meal change how much drug enters the blood. The study also checks safety…

This early-stage trial is testing an investigational drug called MWN109, given as a weekly injection, in Chinese adults who are overweight or obese but do not have diabetes. The study aims to see if the drug is safe and tolerable, and to gather initial information on how it works…

This phase 2 trial tests whether an oral drug called MWN109 can help non-diabetic adults with overweight or obesity lose weight. About 255 participants will take either one of four doses of MWN109 or a placebo daily for 20 weeks. Researchers will measure changes in body weight an…

Researchers are testing an experimental drug called MWN109, given as a weekly injection, in adults who are overweight or obese but do not have diabetes. The study includes 120 participants in China, who will receive either MWN109 or a placebo for 24 weeks. The main goal is to see…

This early-stage trial is testing an investigational drug called MWN109 to see if it is safe and tolerable for people. It involves healthy Chinese volunteers aged 18 to 65 who will receive either the drug or a placebo as a single or multiple injection. The study aims to understan…

This Phase 1 trial in healthy Chinese adults aims to assess the safety and tolerability of an experimental oral drug, MWN109, and how well the body absorbs it. Researchers will also explore whether taking the tablet with or without food changes its effects. The study involves sin…